RELATED CONTENT
NEWS
- Focus on Almirall: partnering, new products and mature markets are key targets
- UK govt offers "step change" in support for regenerative medicine
- In bone drug quandary, FDA seeks panel's advice on safety, 'drug holidays'
- US regulators unveil plan to transform FDA to global agency

